Ying Zhou

A Novel CTLA-4 affinity peptide for cancer immunotherapy by increasing the integrin αvβ3 targeting

Yanfeng Gao, Guodong Li, Guangming Wan, 2022, Discover Oncology.

Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity

Junjian Liu, Chenrong Huang, Yi-cong Bian, 2020, Cancer Immunology, Immunotherapy.

Combined strategies for effective cancer immunotherapy with a novel anti-CD47 monoclonal antibody

Junjian Liu, Ya-Wei Xiong, B. Prinz, 2021, Cancer Immunology, Immunotherapy.

An integrated approach for characterizing immunogenic responses toward a bispecific antibody

Vanessa L. Clark, Rajbharan Yadav, C. Spiess, 2021, mAbs.

Pharmacology, pharmacokinetics, and toxicity characterization of a novel anti-CD73 therapeutic antibody IBI325 for cancer immunotherapy.

Y. Liu, Keai Sinn Tan, Zhihai Wu, 2022, International Journal of Biological Macromolecules.

Liver Metastases across Cancer Types Sharing Tumor Environment Immunotolerance Can Impede Immune Response Therapy and Immune Monitoring.

Jun Zhang, Min Yang, Hao Wang, 2023, Journal of advanced research.